tPA Deficient Plasma is manufactured from normal citrated human plasma that has been depleted of tPA – Tissue-type Plasminogen Activator by selective affinity immuno-adsorption using antibodies directed towards tPA.

Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material. Plasma products are typically buffered with the addition of HEPES to 20mM final concentration and are available in 1.0 mL vials to litre quantities. Our tPA Deficient Plasma can be used for further manufacturing or research use only applications. It has not been validated for use in Thrombin Generation Assays.

Request Certificate of Analysis